VNDA · Company research
Vanda Pharmaceuticals Inc. (VNDA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 4.52 | $302,939,647.1 | 247057647.10 | 114.2500000000000000 | — | — | 5.9953620119139504 | 1.3758414383359448 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.